Výsledky vyhledávání - "Julie E, Dierksheide"

INHIBITION OF HERPES SIMPLEX VIRUS TYPE 1 BY THE EXPERIMENTAL IMMUNOSUPPRESSIVE AGENT LEFLUNOMIDE1

Autor: Julie E. Dierksheide, James W. Williams, Anita S. Chong, Ashley Quintin Hejmanowski, Deborah A. Knight, W. James Waldman

Publikováno v: Transplantation. 71:170-174

Background. Despite advances in antiviral chemotherapy, herpes simplex virus type 1 (HSV-1), continues to complicate the clinical course of many allograft recipients. We have previously demonstrated that the experimental immunosuppressive agent leflu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e68902b572a79701be50a2457cbe10d5
https://doi.org/10.1097/00007890-200101150-00031

Zobrazit plný text záznamu

Abdominal vascular trauma

Autor: Leslie Kobayashi, Julie E Dierksheide, Raul Coimbra, Michelle G Hamel, Todd W. Costantini

Publikováno v: Trauma Surgery & Acute Care Open
Trauma surgery & acute care open, vol 1, iss 1

Abdominal vascular trauma, primarily due to penetrating mechanisms, is uncommon. However, when it does occur, it can be quite lethal, with mortality ranging from 20% to 60%. Increased early mortality has been associated with shock, acidosis, hypother

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e20981baa5ea4da7d25ed677b8b5a6fc
https://doi.org/10.1136/tsaco-2016-000015

Zobrazit plný text záznamu

A phase I study of interleukin 12 with trastuzumab in patients with human epidermal growth factor receptor-2-overexpressing malignancies: analysis of sustained interferon gamma production in a subset of patients

Autor: Robin, Parihar, Padma, Nadella, Adrian, Lewis, Rhonda, Jensen, Carrie, De Hoff, Julie E, Dierksheide, Anne M, VanBuskirk, Cynthia M, Magro, Donn C, Young, Charles L, Shapiro, William E, Carson

Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research. 10(15)

On the basis of preclinical studies, we hypothesized that interleukin (IL)12 would potentiate the antitumor actions of an antihuman epidermal growth factor receptor-2 (HER2) monoclonal antibody (trastuzumab). We conducted a Phase I trial to determine

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::901bec017d06db3a35e1c78ac6748f3f
https://pubmed.ncbi.nlm.nih.gov/15297404

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání